Detalhe da pesquisa
1.
Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study.
Ann Oncol
; 33(9): 929-938, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35680043
2.
Health-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient endometrial cancer in the KEYNOTE-158 study.
Gynecol Oncol
; 166(2): 245-253, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835611
3.
Immune checkpoint inhibitor-based combinations: is dose escalation mandatory for phase I trials?
Ann Oncol
; 30(11): 1751-1759, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31435659
4.
Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages.
Ann Oncol
; 30(8): 1381-1392, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31114846
5.
The complex balance of PI3K inhibition.
Ann Oncol
; 32(2): 127-128, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33272746
6.
Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database.
Ann Oncol
; 25(6): 1222-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24608201
7.
Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study.
Ann Oncol
; 25(9): 1854-1860, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24914041
8.
Patients' selection and trial matching in early-phase oncology clinical trials.
Crit Rev Oncol Hematol
; 196: 104307, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38401694
9.
A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours.
Br J Cancer
; 109(10): 2574-8, 2013 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24149182
10.
A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group.
Br J Cancer
; 109(4): 909-14, 2013 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23922114
11.
A phase 1b study of crenigacestat (LY3039478) in combination with gemcitabine and cisplatin or gemcitabine and carboplatin in patients with advanced or metastatic solid tumors.
Cancer Chemother Pharmacol
; 90(4): 335-344, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36030462
12.
A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region.
Br J Cancer
; 103(2): 165-70, 2010 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-20588273
13.
The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumors.
Ann Oncol
; 25(5): 1074-5, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24651409
14.
Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor.
Sci Rep
; 9(1): 14551, 2019 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601938